Пищевод Барретта в структуре гастроэзофагеальной рефлюксной болезни: современные представления

Е. К. Мастыкова, Конорев Марат Русланович, М. Е. Матвеенко · CyberLeninK (CyberLeninka) · 2010

Literature review demonstrates that Barrett.s esophagus (BE) is a serious complication of gastroesophageal reflux disease (GERD) and the World Gastroenterologists Society views it as a precancerous condition. This problem is important today because BE is associated with an increased risk of the development of esophagus adenocarcinoma. Patients with BE have 30-40 fold increased risk of esophageal adenocarcinoma (EAC) development as compared to the whole population. Risk factors (such as male sex, white race, age more than 60 years, hiatal hernia, obesity, etc.) have a stronger impact in genetically predisposed individuals. Due to asymptomatic disease course, uncontrolled intake of antacid medicines, BE can.t be diagnosed in time in many cases. Modern diagnosing of esophageal metaplasia is performed endoscopically with morphologic verification of the diagnosis made. It is important to size up the length of BE. Longsegment of BE (more than 3 cm) is associated with a greater risk of EAC development. Nowadays, treatment of BE is the same as that of GERD. Proton pump inhibitors (PPI) are the drugs of choice. However, further studies are needed to investigate the possibility to use non-steroid anti-inflammatory drugs (NSAID) and PPI for prevention of EAC development.

Cited by 0 works.

Authors